King of Prussia, PA, United States of America

Ning Wang

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Wang. Retrieved from https://idiyas.com/inventor/ning-wang-dnqhhrg4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ning Wang: Innovator in Pharmaceutical Compounds

Introduction

Ning Wang is a notable inventor based in King of Prussia, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on amide compounds. Her research and inventions have the potential to impact various therapeutic applications.

Latest Patents

Ning Wang holds a patent for "Amide compounds and methods of using the same." This patent discloses a compound characterized by a specific formula, including pharmaceutically acceptable salts or solvates. The pharmaceutical compositions containing these compounds are particularly useful as LXR agonists, which can play a crucial role in treating various medical conditions.

Career Highlights

Ning Wang is currently employed at SmithKline Corporation, where she continues to advance her research in pharmaceutical sciences. Her work has led to the development of innovative compounds that may enhance treatment options in the medical field.

Collaborations

Ning has collaborated with esteemed colleagues such as Scott Kevin Thompson and James S Frazee. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Ning Wang's contributions to the field of pharmaceuticals through her patent on amide compounds exemplify her dedication to innovation. Her work at SmithKline Corporation and collaborations with other professionals highlight her impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…